Magnolol protects against MPTP/MPP + -induced toxicity via inhibition of oxidative stress in in vivo and in vitro models of Parkinson's disease

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Muroyama, Akiko ^a   Fujita, Aya ^a   Lv, Cheng ^a   Kobayashi, Shota ^a   Fukuyama, Yoshiyasu ^b   Mitsumoto, Yasuhide ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; MAGNOLOL; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; DISEASE MODEL; DOPAMINERGIC SYSTEM; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; MOUSE; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONTENT; TREATMENT DURATION; WESTERN BLOTTING;

EID: 84862288739     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/985157     Document Type: Article

References (50)

1. Dauer W., Przedborski S., Parkinson's disease: mechanisms and models Neuron 2003 39 6 889 909 (Pubitemid 37130207)
2. Jankovic J., Aguilar L. G., Current approaches to the treatment of Parkinson's disease Neuropsychiatric Disease and Treatment 2008 4 4 743 757
3. Langston J. W., Ballard P., Tetrud J. W., Irwin I., Chronic parkinsonism in humans due to a product of meperidine-analog synthesis Science 1983 219 4587 979 980 (Pubitemid 13189531)
4. Burns R. S., Chiueh C. C., Markey S. P., A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Proceedings of the National Academy of Sciences of the United States of America 1983 80 14 4546 4550 (Pubitemid 13077876)
5. Jenner P., Functional models of Parkinson's disease: a valuable tool in the development of novel therapies Annals of Neurology 2008 64 2 S16 S29
6. Parker W. D., Boyson S. J., Parks J. K., Abnormalities of the electron transport chain in idiopathic Parkinson's disease Annals of Neurology 1989 26 6 719 723 (Pubitemid 20011004)
7. Schapira A. H. V., Cooper J. M., Dexter D., Jenner P., Clark J. B., Marsden C. D., Mitochondrial complex I deficiency in Parkinson's disease Lancet 1989 1 8649 1269 (Pubitemid 19140359)
8. Mizuno Y., Yoshino H., Ikebe S. I., Hattori N., Kobayashi T., Shimoda-Matsubayashi S., Matsumine H., Kondo T., Mitochondrial dysfunction in Parkinson's disease Annals of Neurology 1998 44 3 S99 S109
9. Saggu H., Cooksey J., Dexter D., Wells F. R., Lees A., Jenner P., Marsden C. D., A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra Journal of Neurochemistry 1989 53 3 692 697 (Pubitemid 19207359)
10. Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., Marsden C. D., Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Annals of Neurology 1994 36 3 348 355 (Pubitemid 24280055)
11. Hasegawa E., Takeshige K., Oishi T., Murai Y., Minakami S., 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles Biochemical and Biophysical Research Communications 1990 170 3 1049 1055 (Pubitemid 20273373)
12. Sriram K., Pai K. S., Boyd M. R., Ravindranath V., Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice Brain Research 1997 749 1 44 52 (Pubitemid 27096453)
13. Fujita M., Itokawa H., Sashida Y., Studies on the components of Magnolia obovata Thunb. III. Occurrence of magnolol and honokiol in M. obovata and other allied plants (Japanese) Yakugaku Zasshi 1973 93 4 429 434
14. Maruyama Y., Kuribara H., Overview of the pharmacological features of honokiol CNS Drug Reviews 2000 6 1 35 44 (Pubitemid 30179968)
15. Kuribara H., Stavinoha W. B., Maruyama Y., Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice Journal of Pharmacy and Pharmacology 1998 50 7 819 826 (Pubitemid 28379279)
16. Xu Q., Yi L. T., Pan Y., Wang X., Li Y. C., Li J. M., Wang C. P., Kong L. D., Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008 32 3 715 725 (Pubitemid 351312371)
17. Matsui N., Nakashima H., Ushio Y., Tada T., Shirono A., Fukuyama Y., Nakade K., Zhai H., Yasui Y., Fukuishi N., Akagi R., Akagi M., Neurotrophic effect of magnolol in the hippocampal CA1 region of Senescence-Accelerated Mice (SAMP1) Biological and Pharmaceutical Bulletin 2005 28 9 1762 1765 (Pubitemid 41324148)
18. Lin Y. R., Chen H. H., Ko C. H., Chan M. H., Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage European Journal of Pharmacology 2006 537 13 64 69
19. Chen C. M., Liu S. H., Lin-Shiau S. Y., Honokiol, a neuroprotectant against mouse cerebral ischaemia, mediated by preserving Na +, K + -ATPase activity and mitochondrial functions Basic and Clinical Pharmacology and Toxicology 2007 101 2 108 116
20. Matsui N., Takahashi K., Takeichi M., Kuroshita T., Noguchi K., Yamazaki K., Tagashira H., Tsutsui K., Okada H., Kido Y., Yasui Y., Fukuishi N., Fukuyama Y., Akagi M., Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice Brain research 2009 1305 108 117
21. Chen H.-H., Lin S.-C., Chan M.-H., Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism Neurodegenerative Diseases 2011 8 5 364 374
22. Fukuyama Y., Nakade K., Minoshima Y., Yokoyama R., Zhai H., Mitsumoto Y., Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons Bioorganic and Medicinal Chemistry Letters 2002 12 8 1163 1166 (Pubitemid 34270554)
23. Zhai H., Nakade K., Oda M., Mitsumoto Y., Akagi M., Sakurai J., Fukuyama Y., Honokiol-induced neurite outgrowth promotion depends on activation of extracellular signal-regulated kinases (ERK1/2) European Journal of Pharmacology 2005 516 2 112 117 (Pubitemid 40799346)
24. Zhai H., Nakade K., Mitsumoto Y., Fukuyama Y., Honokiol and magnolol induce Ca 2+ mobilization in rat cortical neurons and human neuroblastoma SH-SY5Y cells European Journal of Pharmacology 2003 474 2-3 199 204 (Pubitemid 37281449)
25. Mori A., Ohashi S., Nakai M., Moriizumi T., Mitsumoto Y., Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice Neuroscience Research 2005 51 3 265 274 (Pubitemid 40248549)
26. Kawasaki T., Ishihara K., Ago Y., Baba A., Matsuda T., Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum Journal of Pharmacology and Experimental Therapeutics 2007 322 1 274 281 (Pubitemid 46956378)
27. Hattori M., Endo Y., Takebe S., Metabolism of magnolol from magnoliae cortex. II. Absorption, metabolism and excretion of [ring- 14 C]magnolol in rats Chemical and Pharmaceutical Bulletin 1986 34 1 158 167 (Pubitemid 16135903)
28. Tsai T. H., Chou C. J., Chen C. F., Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection Journal of Pharmacy and Pharmacology 1996 48 1 57 59 (Pubitemid 26128686)
29. O'Callaghan J. P., Miller D. B., Reinhard J. F., Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Brain Research 1990 521 1-2 73 80 (Pubitemid 20208736)
30. Dringen R., Pfeiffer B., Hamprecht B., Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione Journal of Neuroscience 1999 19 2 562 569 (Pubitemid 29036007)
31. Hirrlinger J., Schulz J. B., Dringen R., Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells Journal of Neuroscience Research 2002 69 3 318 326 (Pubitemid 34809481)
32. Batchelor P. E., Liberatore G. T., Wong J. Y. F., Porritt M. J., Frerichs F., Donnan G. A., Howells D. W., Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor Journal of Neuroscience 1999 19 5 1708 1716 (Pubitemid 29094189)
33. Lo Y. C., Teng C. M., Chen C. F., Chen C. C., Hong C. Y., Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation Biochemical Pharmacology 1994 47 3 549 553
34. Haraguchi H., Ishikawa H., Shirataki N., Fukuda A., Antiperoxidative activity of neolignans from Magnolia obovata Journal of Pharmacy and Pharmacology 1997 49 2 209 212 (Pubitemid 27096118)
35. Lee J., Jung E., Park J., Jung K., Lee S., Hong S., Park J., Park E., Kim J., Park S., Park D., Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF- B activation signaling Planta Medica 2005 71 4 338 343 (Pubitemid 40676458)
36. Kong L. D., Cheng C. H. K., Tan R. X., Inhibition of MAO a and B by some plant-derived alkaloids, phenols and anthraquinones Journal of Ethnopharmacology 2004 91 2-3 351 355 (Pubitemid 38561134)
37. Heikkila R. E., Manzino L., Cabbat F. S., Duvoisin R. C., Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine by monoamine oxidase inhibitors Nature 1984 311 5985 467 469 (Pubitemid 14035453)
38. Javitch J. A., D'Amato R. J., Strittmatter S. M., Snyder S. H., Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity Proceedings of the National Academy of Sciences of the United States of America 1985 82 7 2173 2177 (Pubitemid 15056491)
39. Ramsay R. R., Singer T. P., Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine, by mitochondria Journal of Biological Chemistry 1986 261 17 7585 7587 (Pubitemid 17208669)
40. Nicklas W. J., Vyas I., Heikkila R. E., Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Life Sciences 1985 36 26 2503 2508 (Pubitemid 15072756)
41. Chan P., DeLanney L. E., Irwin I., Langston J. W., Di Monte D., Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain Journal of Neurochemistry 1991 57 1 348 351
42. Nakai M., Mori A., Watanabe A., Mitsumoto Y., 1-Methyl-4-phenylpyridinium (MPP +) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential ( m) in rat striatum Experimental Neurology 2003 179 1 103 110 (Pubitemid 36062623)
43. Zhang Y., Marcillat O., Giulivi C., Ernster L., Davies K. J. A., The oxidative inactivation of mitochondrial electron transport chain components and ATPase Journal of Biological Chemistry 1990 265 27 16330 16336
44. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D. M., Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine Neuroscience 1995 67 3 631 647
45. Holtz W. A., Turetzky J. M., Jong Y. J. I., O'Malley K. L., Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics Journal of Neurochemistry 2006 99 1 54 69 (Pubitemid 44395130)
46. Cohen G., Heikkila R. E., The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6 hydroxydopamine, dialuric acid, and related cytotoxic agents Journal of Biological Chemistry 1974 249 8 2447 2452
47. Kumar R., Agarwal A. K., Seth P. K., Free radical-generated neurotoxicity of 6-hydroxydopamine Journal of Neurochemistry 1995 64 4 1703 1707
48. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R., Greenberg M. E., Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 1997 275 5300 661 665 (Pubitemid 27061332)
49. Malagelada C., Zong H. J., Greene L. A., RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation Journal of Neuroscience 2008 28 53 14363 14371
50. Aleyasin H., Rousseaux M. W. C., Marcogliese P. C., Hewitt S. J., Irrcher I., Joselin A. P., Parsanejad M., Kim R. H., Rizzu P., Callaghan S. M., Slacka R. S., Mak T. W., Park D. S., DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway Proceedings of the National Academy of Sciences of the United States of America 2010 107 7 3186 3191